Demographic, anamnestic and clinical data of patients with infective endocarditis and COVID-19
O. V. Petrova,
D. K. Tverdokhlebova,
I. G. Dzhalalova,
L. A. Biryukova,
Sh. I. Abdirimov,
N. R. Zarandia,
D. M. Nikulina,
S. A. Shashin,
V. N. Kolesnikov https://doi.org/10.17021/2712-8164-2025-4-45-53
Abstract
Demographic, anamnestic and clinical data are of particular diagnostic and prognostic importance in patients with cardiovascular diseases, and have not previously been studied in patients with infective endocarditis and coronavirus infection. The aim. To study demographic, anamnestic and clinical data of patients with infective endocarditis and coronavirus infection upon admission to the hospital. Materials and methods. A retrospective analysis of the data of 69 patients with infective endocarditis who were treated at the Federal State Budgetary Institution Federal Center of Cardiovascular Surgery of the Ministry of Health of the Russian Federation (Astrakhan) from 2019 to 2023 was carried out. To study the significance of demographic, anamnestic and clinical data of patients with infective endocarditis, depending on the presence or absence of Covid-19, they were divided into 2 groups: group 1 consisted of 24 patients with infective endocarditis and laboratory-confirmed Covid-19; group 2 – 45 patients with infectious endocarditis without Covid-19. Results. The study of demographic, anamnestic and clinical data of patients with infective endocarditis and coronavirus infection allowed us to identify a group of patients with coronavirus infection with a high risk of developing infective endocarditis: males aged 44 to 64 years, with primary infective endocarditis with aortic valve damage.
About the Authors
O. V. Petrova
Federal Center of Cardiovascular Surgery
Russian Federation
Russian Federation
Olga V. Petrova, Dr. Sci. (Med.), Professor, Head of the Laboratory
Astrakhan
D. K. Tverdokhlebova
Federal Center of Cardiovascular Surgery
Russian Federation
Russian Federation
Diana K. Tverdokhlebova, physician clinical laboratory diagnostics
Astrakhan
I. G. Dzhalalova
Federal Center of Cardiovascular Surgery
Russian Federation
Russian Federation
Irina G. Dzhalalova, physician clinical laboratory diagnostics
Astrakhan
L. A. Biryukova
Federal Center of Cardiovascular Surgery
Russian Federation
Russian Federation
Lyubov A. Biryukova, Cand. Sci. (Med.), cardiologist
Astrakhan
Sh. I. Abdirimov
Federal Center of Cardiovascular Surgery
Russian Federation
Russian Federation
Shokhrukh I. Abdirimov, interventional radiologist
Astrakhan
N. R. Zarandia
Federal Center of Cardiovascular Surgery
Russian Federation
Russian Federation
Nina R. Zarandia, interventional radiologist
Astrakhan
D. M. Nikulina
Astrakhan State Medical University
Russian Federation
Russian Federation
Dina M. Nikulina, Dr. Sci. (Med.), Professor, Head of the Department
Astrakhan
S. A. Shashin
Astrakhan State Medical University
Russian Federation
Russian Federation
Sergey A. Shashin, Dr. Sci. (Med.), Professor, Professor of the Department
Astrakhan
V. N. Kolesnikov
Federal Center of Cardiovascular Surgery
Russian Federation
Russian Federation
Vladimir N. Kolesnikov, Cand. Sci. (Med.), Chief Physician
Astrakhan
References
1. Danilov A. I., Kozlov R. S., Kozlov S. N., Evseev A. V. Practice microbiological diagnosis of infective endocarditis in the Federation. Vestnik of the Smolensk State Medical Academy = Vestnik Smolenskoy Gosudarstvennoy Medicinskoy Academy. 2019; 18 (1): 90–94 (In Russ.).
2. Danilov A. I., Kozlov R. S., Evseev A. V. Updated recommendations of the European society of cardiolocy for the management of patients infective endocarditis. Vestnik of the Smolensk State Medical Academy = Vestnik Smolenskoy Gosudarstvennoy Medicinskoy Academy. 2017; 16 (1): 63–69 (In Russ.).
3. Petrova О. V., Tverdokhlebova D. K., Shashin S. A., Nikulina D. M., Kolesnikov V. N. Microorganisms and peculiarities of the course of the postoperative period in patients with infective endocarditis and COVID-19. Astrakhan Medical Journal = Astrakhan Medical Journal. 2024; 19 (4): 85–91. doi:10.17021/1992-6499-2024-4-85-91 (In Russ.).
4. Tverdokhlebova D. K., Petrova O. V., Litvinova I. N., Smel’tsova E. V., Kurashenko O. O. Longterm persistence of SARS-CoV-2 in a patient with infectious endocarditis and COVID-19: a clinical case. Prikaspiyskiy zhurnal meditsiny i farmatsii = Caspian Journal of Medicine and Pharmacy. 2024; 5 (3): 28–33. doi: 10.17021/2712-8164-2024-3-28-33 (In Russ.).
5. Butler N. R., Courtney Р. A., Swegle J. Endocarditis. Primary Care. 2024; 51 (1): 155–159. doi: 10.1016/j.pop.2023.07.009.
6. El-Dalati S., Cronin D., Shea M., Weinberg R., Riddell J., Washer L., Shuman E., Burke J., Murali S., Fagan C., Patel T., Ressler K., Deeb G. M. Clinical practice update on infections endocarditis. American Journal of Medicine. 2020; 133 (1): 44–49. doi: 10.1016/j.amjmed.2019.08.022.
7. Li Y., Ji D., Cai W., Hu Y., Bai Y., Wu J., Xu J. Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid repositive patients: A literature review. J Med Virol. 2021; 93 (3): 1288–1295. doi: 10.1002/jmv.26491.
8. Ao Z., Li Y., Wei J., Jiang J., Wang X., Zhang P., Liu Y., Yu H., Zhu L., Wang X., Hu Q., Duan J., Hu W., Zhang X., Wu G., Guo S. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study. Clin Exp Med. 2021; 21 (3): 361–367. doi: 10.1007/s10238-021-00687-y.
9. Wang Z., Feng Z., Tang S., Zeng J., Ning H., Huang C., Zhang L. Resurgence of Positive qRT-PCR test results in patients recovered from COVID-19: case reports. Am J Med Sci. 2021; 361 (5): 650–654. doi: 10.1016/j.amjms.2021.01.019.
10. Huang K., Liu W., Zhou J., Wang Y., Zhang Y., Tang X., Liang J., Bi F.F. Repositive RT-PCR test in discharged COVID-19 patients during medical isolation observation. Int J Med Sci. 2021; 18 (12): 2545–2550. doi: 10.7150/ijms.58766.
11. Song K. H., Kim D. M., Lee H., Ham S. Y., Oh S. M., Jeong H., Jung J., Kang C. K., Park J. Y., Kang Y. M., Kim J. Y., Park J. S., Park K. U., Kim E. S., Kim H. B. Dynamics of viral load and anti-SARS-CoV-2 antibodies in pa-tients with positive RT-PCR results after recovery from COVID-19. Korean J In-tern Med. 2021; 36 (1): 11–14. doi: 10.3904/kjim.2020.325.
12. Xia J., Zeng Y., Tan Z., Chen T., Hu W., Shuai S., Cao D., Zeng X. Differentials of SARS-CoV-2 Viral RNA Re-positivity in discharged COVID-19 patients. AIDS Rev. 2021; 23 (3): 153–163. doi: 10.24875/AIDSRev.21000023.
13. Tang X., Musa S. S., Zhao S., He D. Reinfection or reactivation of severe acute respiratory syndrome coronavirus 2: A systematic review. Front Public Health. 2021; 9: 663045. doi: 10.3389/fpubh.2021.663045.
14. Kotova E. O., Pisaryuk A. S., Kobalava Zh. D., Timofeeva Yu. A., Chipigina N.S., Karaulova Yu. N., Ezhova L. C. Infective endocarditis and Covid-19: the impact of Sars-Co-V-2 infection on diagnostics, course, and prognosis. Russkiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2023; 28 (1): 5229. doi:10.15829/1560-4071-2023-5229 (In Russ.).
15. Petrova O. V. Molekulyarnye prediktory oslozhneniy v rannem posleoperatsionnom periode u kardiokhirurgicheskikh bolnykh = Molecular predictors of complications in the early postoperative period in cardiac surgery patients: Thesis of Doctor of Medical Sciences. Astrakhan; 2022: 274 p. (In Russ.).
16. Volk L., Verghis N., Chiricolo A., Ikegami H., Lee L., Lemaire A. Early and intermediate outcome for surgical management of infective endocarditis. J Cardiothorac Surg. 2019; 14: 211. doi: 10.1186/s13019-019-1029-1.
Review
For citations:
Petrova O.V., Tverdokhlebova D.K., Dzhalalova I.G., Biryukova L.A., Abdirimov Sh.I., Zarandia N.R., Nikulina D.M., Shashin S.A., Kolesnikov V.N. Demographic, anamnestic and clinical data of patients with infective endocarditis and COVID-19. Title. 2025;6(4):45-53. (In Russ.) https://doi.org/10.17021/2712-8164-2025-4-45-53
Views:
29
Email this article 